Macrogenics (MGNX) Long-Term Investments (2016 - 2026)

Macrogenics (MGNX) has reported Long-Term Investments for 11 consecutive years, with $87.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Long-Term Investments rose 923.36% year-over-year to $87.7 million; the TTM figure through Mar 2026 stood at $87.7 million (up 923.36% YoY), while the FY2025 annual figure was $132.7 million, up 605.83% from the prior year.
• Long-Term Investments retreated to $87.7 million in Q1 2026 per MGNX's latest filing, from $132.7 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $166.5 million in Q3 2023 and bottomed at $8.6 million in Q1 2025.
• Historically, Long-Term Investments has averaged $77.6 million across 5 years, with a median of $66.3 million in 2025.
• Annual changes were most pronounced in 2025 — Long-Term Investments slumped 91.75% — and 2026, when it jumped 923.36%.
• Macrogenics' Long-Term Investments stood at $45.5 million in 2022, then jumped by 183.18% to $128.8 million in 2023, then plunged by 85.41% to $18.8 million in 2024, then jumped by 605.83% to $132.7 million in 2025, then plunged by 33.9% to $87.7 million in 2026.
• Business Quant data shows MGNX's Long-Term Investments at $87.7 million in Q1 2026, $132.7 million in Q4 2025, and $66.3 million in Q3 2025.